upadacitinib UC
Selected indexed studies
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. (Gastroenterology, 2024) [PMID:39572132]
- Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis. (Gastroenterology, 2024) [PMID:39425738]
- Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study. (J Crohns Colitis, 2025) [PMID:39605286]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. (2024) pubmed
- Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning. (2025) pubmed
- Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis. (2024) pubmed
- Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience. (2023) pubmed
- Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study. (2025) pubmed
- Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease. (2025) pubmed
- Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment. (2023) pubmed
- Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease. (2024) pubmed
- Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis. (2020) pubmed
- Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis. (2025) pubmed